Gynecomastia may occur as a side effect of Risperdal use, as the antipsychotic could increase the amount of the hormone prolactin in the blood. Prolactin is a protein hormone that induces and maintains lactation in women after they give birth, but it may cause boys taking the antipsychotic medication to develop breasts.
Risperdal (risperidone) is a widely used antipsychotic medication which has been widely used by many children for treatment of bipolar disorders, autism, irritability, aggression and behavior disorders. Many of these uses were off-label and never approved by the FDA as safe and effective treatments.
It appears that Johnson & Johnson failed to provide adequate warnings and information about the risk of potential Risperdal gynecomastia side effects. You can also consult a Risperdal gynecomastia lawyer if you need a legal advice to solve your issues.
These problems often go undiagnosed when breasts first develop, because doctors or family members attribute it to weight gain that is also frequently seen with Risperdal use.
In many cases, breast growth from Risperdal can cause serious problems and consequences, often leading to the need for gynecomastia surgery to remove the breast gland.
Risperdal Gynecomastia: Causes, Symptoms, and Treatment
Gynecomastia is the medical term for the development of breast tissue in males. Risperdal’s link to gynecomastia has been well-documented. Experts believe that Risperdal-induced gynecomastia develops because Risperdal works to block dopamine and, as a result, the pituitary gland releases prolactin, a hormone that stimulates breast development and milk production in women.
The company’s own prescribing information includes the results of a study which found heightened levels of prolactin in:
- 82% to 87% of young men and boys with schizophrenia or bipolar disorder taking Risperdal.
- 49% of young men and boys suffering from autism and certain other ailments taking Risperdal.